Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Novartis to build manufacturing hub in North Carolina, creating 700 jobs - 2Manual for Picking Coastline Travel
- 3RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record
- 4Was This Driver Simply Having Some good times Or Behaving Like An Ass?
- 5Kidneys from Black donors are more likely to be thrown away − a bioethicist explains why
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- 6 Famous kind of practice on the planet
- Audits of 6 European Busssiness Class Flights
- Horses really can smell our fear, new study finds
- Must-Have Wellness Gear: What to Purchase for Successful Exercises
- Schools to start reopening after Nigeria mass abduction
- Picking the Right Pot for Your Plants: An Aide for Plant Devotees
- Most loved Amusement Park for Small children: Which One Do You Suggest?
- Cyber Monday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60%
